BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 26056355)

  • 21. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients.
    Ozawa PMM; Vieira E; Lemos DS; Souza ILM; Zanata SM; Pankievicz VC; Tuleski TR; Souza EM; Wowk PF; Urban CA; Kuroda F; Lima RS; Almeida RC; Gradia DF; Cavalli IJ; Cavalli LR; Malheiros D; Ribeiro EMSF
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candidate miRNAs in human breast cancer biomarkers: a systematic review.
    Adhami M; Haghdoost AA; Sadeghi B; Malekpour Afshar R
    Breast Cancer; 2018 Mar; 25(2):198-205. PubMed ID: 29101635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
    McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
    PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
    Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.
    Markou A; Zavridou M; Sourvinou I; Yousef G; Kounelis S; Malamos N; Georgoulias V; Lianidou E
    Clin Chem; 2016 Jul; 62(7):1002-11. PubMed ID: 27197674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
    BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute quantification of cell-free microRNAs in cancer patients.
    Ferracin M; Lupini L; Salamon I; Saccenti E; Zanzi MV; Rocchi A; Da Ros L; Zagatti B; Musa G; Bassi C; Mangolini A; Cavallesco G; Frassoldati A; Volpato S; Carcoforo P; Hollingsworth AB; Negrini M
    Oncotarget; 2015 Jun; 6(16):14545-55. PubMed ID: 26036630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.
    Yong FL; Law CW; Wang CW
    BMC Cancer; 2013 Jun; 13():280. PubMed ID: 23758639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentially expressed microRNAs in postpartum breast cancer in Hispanic women.
    Muñoz-Rodríguez JL; Vrba L; Futscher BW; Hu C; Komenaka IK; Meza-Montenegro MM; Gutierrez-Millan LE; Daneri-Navarro A; Thompson PA; Martinez ME
    PLoS One; 2015; 10(4):e0124340. PubMed ID: 25875827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
    Madhavan D; Peng C; Wallwiener M; Zucknick M; Nees J; Schott S; Rudolph A; Riethdorf S; Trumpp A; Pantel K; Sohn C; Chang-Claude J; Schneeweiss A; Burwinkel B
    Carcinogenesis; 2016 May; 37(5):461-70. PubMed ID: 26785733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
    BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.